Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection - excipient ingredients: mannitol; water for injections; sodium hydroxide; sulfuric acid - this medicine is indicated in certain diseases of the blood and in certain tumours.

Írsko - angličtina - HPRA (Health Products Regulatory Authority)

hospira uk ltd - vincristine sulfate - solution for injection - 5 mg/5ml

Nový Zéland - angličtina - Medsafe (Medicines Safety Authority)

link pharmaceuticals ltd - colistimethate sodium 384.6 mg/ml - powder for injection - 150 mg/2ml - active: colistimethate sodium 384.6 mg/ml - the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli; particularly when the infection is caused by sensitive strains of pseudomonas aeruginosa, and the following gram-negative organisms; aerobacter aerogenes, escherichia coli, klebsiella pneumoniae. pending results of appropriate bacteriologic cultures and sensitivity tests, colistimethate sodium may be used to initiate therapy in serious infections that are suspected to be due to gram-negative organisms.

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; sodium hydroxide; sulfuric acid; water for injections - chile vincristine sulfate is indicated alone or in combination with other antitumor therapies for the treatment of: ? leukaemias, including acute lymphocytic leukaemia, chronic lymphocytic leukaemia, acute myelogenous leukaemia and blastic crisis of chronic mylogenous leukaemia. ? malignant lymphomas, including hodgkin?s disease and non-hodgkin?s lymphomas ? lung cancer (small cell bronchogenic carcinoma) ? wilms? tumor ? neuroblastoma ? ewing?s sarcomas ? true idiopathic thrombocytopenic purpura ? rhabdomyosarcoma ? osteogenic sarcoma ? mycosis fungoides ? uterine cervix cancer ? malignant melanoma ? breast carcinoma croatia vincristine is used primarily in the treatment of acute leukaemia, usually as a component of various chemotherapeutic regimens. it has also been used as part of combination therapy in the treatment of hodgkin's disease, non-hodgkin's malignant lymphomas, rhabdomyosarcoma, neuroblastoma, wilm's tumour, osteogenic sarcoma, mycosis fungoides, ewing's sarcoma, carcinoma of the uterine cervix, breast cancer, malignant melanoma, oat-cell carcinoma of the lung and gynaecological tumours of childhood. vincristine may be useful in patients with true idiopathic thrombocytopenic purpura resistant to the usual treatment but is not recommended as primary treatment for this disorder.

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

divasa-farmavic s.a. - colistin sulfate - eq. colistin 2000000 iu/ml - solution for use in drinking water - 2 miu/ml - colistin sulfate - colistin - poultry; cattle; sheep; pig

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

emdoka s.p.r.l.-b.v.b.a. - colistin sulfate 100 mg/g - eq. colistin 1,9 10*6 iu - powder for use in drinking water/milk - 10 % - colistin sulfate 100 mg/g - colistin - cattle; pig

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

emdoka s.p.r.l.-b.v.b.a. - colistin sulfate 500 mg/g - eq. colistin 9,5 10*6 iu - powder for use in drinking water/milk - 50 % - colistin sulfate 500 mg/g - colistin - cattle; pig

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

emdoka s.p.r.l.-b.v.b.a. - colistin sulfate 160 - eq. colistin 3 - tablet - 3000000 i.u. - colistin sulfate 3000000 iu - colistin - cattle

Belgicko - angličtina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

livisto int'l s.l. - colistin sulfate - eq. colistin 5 10*6 iu/ml - concentrate for oral solution - 5000000 iu/ml - colistin sulfate - colistin - cattle; pig; sheep; poultry

Austrália - angličtina - Department of Health (Therapeutic Goods Administration)

pfizer (perth) pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; sulfuric acid; water for injections; sodium hydroxide - in combination with other chemotherapeutic agents, vincristine is indicated for the treatment of acute leukaemia and malignant lymphomas, including hodgkin?s disease, lymphosarcoma and reticulosarcoma.